Moderna Inc (MRNA)

Exchange
NASDAQ
Symbol
MRNA
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
Country
USA

Stock price

At close: March 7, 2025

  • Open
    34.47
  • High
    37.91
  • Low
    33.93
  • Close
    35.61
  • Volume
    17,337,700

Financial ratios

Dec 31, 2023